CA-MASIMO

Masimo
(NASDAQ: MASI), a global innovator of noninvasive patient monitoring
technologies, announced today that retired Senator Tom Harkin, former
five-term U.S. Senator and former Chairman of the Senate Health,
Education, Labor and Pension (HELP) Committee, has been elected to
Masimo’s Board of Directors.

Senator Harkin retired from the U.S. Senate in January 2015. Senator
Harkin was chairman of the Senate HELP Committee for eight years. In
that role, he worked to ensure the health of our economy, guarantee
access to quality education, and provide affordable, quality health care
for all Americans. Senator Harkin crafted the prevention and wellness
title of the country’s new health reform bill, the Patient Protection
and Affordable Care Act. Senator Harkin’s signature legislation
achievement was leading the effort and sponsorship of the Americans with
Disabilities Act (ADA) signed into law in 1990 by President George H.W.
Bush. He later created the Clinical Trials Network to measure the
effectiveness of rehabilitation therapies for those living with
paralysis, and drafted the Christopher and Dana Reeve Act, passed in
2009. Prior to his retirement, Senator Harkin worked closely with
President Obama to lift restrictions on embryonic stem cell research.

“For years, Tom has worked tirelessly to ensure that everyone has access
to affordable, quality health care and those who are in need are not
forgotten. We are honored to welcome Tom to the Board,” said Joe Kiani,
Chairman and CEO of Masimo. “We believe his integrity, extensive
experience and insight into our complex health system, along with his
dedication and passion to help those in need will be extremely valuable
to Masimo.”

“I’ve been very impressed with Masimo’s innovations and contributions to
healthcare,” said Harkin. “I got to know Joe through his advocacy work
to improve competition in healthcare, align misaligned incentives that
impede patient care and the Patient Safety Movement. He has been
steadfast in his commitment to improve our healthcare system through
innovation and advocacy. I look forward to working with him and the rest
of the board to help Masimo with its mission to improve patient care and
reduce cost of care.”

Senator Harkin was first elected to the U.S. House of Representatives in
1974, and 10 years later, he was elected to US Senate. Senator Harkin
was born in Cumming, Iowa, where he still resides with his wife Ruth.
They have two daughters and three grandchildren.

Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through-Motion and Low Perfusion™
pulse oximetry,
which has been shown in multiple studies to significantly reduce false
alarms and accurately monitor for true alarms. The benefits of Masimo
SET® have been proven in more than 100 independent and objective studies
and it is estimated to be used on more than 100 million patients in
leading hospitals and other healthcare settings around the world. In
2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing
noninvasive and continuous monitoring of blood constituents that
previously could only be measured invasively, including total hemoglobin
(SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®),
methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition
to SpO2, pulse rate, and perfusion index (PI). Additional information
about Masimo and its products may be found at www.masimo.com
.